Minerva Total Assets from 2010 to 2024

NERV Stock

USD 2.26 0.02 0.89%

Minerva Neurosciences Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2012-12-31

Previous Quarter

46.3 M

Current Value

42.8 M

Quarterly Volatility

8.5 B

Yuan Drop

Covid

Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.4 K, Interest Expense of 8.7 M or Selling General Administrative of 10.9 B, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.

Check out the analysis of Minerva Neurosciences Correlation against competitors.

For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

Latest Minerva Neurosciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of Minerva Neurosciences over the last few years. Total assets refers to the total amount of Minerva Neurosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Minerva Neurosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Minerva Neurosciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 56.9 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Minerva Total Assets Regression Statistics

	Arithmetic Mean	69,925,395
	Geometric Mean	23,946,941
	Coefficient Of Variation	75.57
	Mean Deviation	38,871,447
	Median	68,450,540
	Standard Deviation	52,839,255
	Sample Variance	2792T
	Range	183.5M
	R-Value	0.42
	Mean Square Error	2480T
	R-Squared	0.18
	Significance	0.12
	Slope	4,945,350
	Total Sum of Squares	39087.8T

Minerva Total Assets History

	2024	88 M
	2023	56.9 M
	2022	55.1 M
	2021	77.1 M
	2020	57.6 M
	2019	77.5 M
	2018	139.1 M

Other Fundumenentals of Minerva Neurosciences

Intangibles To Total Assets

Minerva Neurosciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Accounts Payable	Good Will	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock	Net Receivables
Total Assets		0.76	-0.43	-0.34	0.48	0.96	0.7	0.72	0.63	0.69	0.36	0.39	0.38	0.64	0.49	0.35	0.63	-0.63	-0.05	-0.05	0.03	-0.06
Total Stockholder Equity	0.76		-0.72	0.26	-0.1	0.66	0.7	0.33	0.19	0.24	0.33	0.83	0.37	0.95	0.01	0.59	0.24	-0.2	0.55	0.4	0.58	0.46
Net Debt	-0.43	-0.72		-0.22	0.15	-0.41	-0.77	-0.18	-0.24	-0.07	-0.32	-0.55	-0.11	-0.66	0.0	-0.13	-0.24	0.19	-0.42	-0.27	-0.78	-0.58
Retained Earnings	-0.34	0.26	-0.22		-0.82	-0.42	-0.28	-0.73	-0.7	-0.79	-0.05	0.66	-0.34	0.39	-0.93	0.52	-0.78	0.83	0.95	0.91	0.64	0.52
Total Liab	0.48	-0.1	0.15	-0.82		0.58	0.23	0.71	0.74	0.73	0.14	-0.45	-0.01	-0.23	0.82	-0.22	0.72	-0.75	-0.74	-0.59	-0.59	-0.3
Total Current Assets	0.96	0.66	-0.41	-0.42	0.58		0.67	0.67	0.67	0.65	0.35	0.24	0.29	0.57	0.6	0.28	0.73	-0.73	-0.15	-0.12	-0.04	-0.07
Common Stock	0.7	0.7	-0.77	-0.28	0.23	0.67		0.63	0.63	0.54	0.29	0.32	0.52	0.6	0.49	0.09	0.57	-0.59	-0.02	-0.22	0.5	0.33
Current Deferred Revenue	0.72	0.33	-0.18	-0.73	0.71	0.67	0.63		0.74	0.99	0.16	-0.02	0.51	0.14	0.75	-0.08	0.73	-0.74	-0.5	-0.53	-0.26	-0.17
Accounts Payable	0.63	0.19	-0.24	-0.7	0.74	0.67	0.63	0.74		0.75	0.27	-0.16	0.12	0.08	0.75	-0.2	0.75	-0.77	-0.55	-0.54	-0.16	-0.26
Good Will	0.69	0.24	-0.07	-0.79	0.73	0.65	0.54	0.99	0.75		0.14	-0.11	0.5	0.06	0.77	-0.13	0.73	-0.75	-0.58	-0.58	-0.38	-0.33
Short Term Debt	0.36	0.33	-0.32	-0.05	0.14	0.35	0.29	0.16	0.27	0.14		0.32	0.09	0.26	0.18	-0.16	0.19	-0.23	0.04	-0.01	0.12	0.1
Intangible Assets	0.39	0.83	-0.55	0.66	-0.45	0.24	0.32	-0.02	-0.16	-0.11	0.32		0.11	0.84	-0.48	0.66	-0.26	0.32	0.85	0.73	0.65	0.52
Property Plant Equipment	0.38	0.37	-0.11	-0.34	-0.01	0.29	0.52	0.51	0.12	0.5	0.09	0.11		0.28	0.4	0.03	0.31	-0.37	-0.15	-0.4	0.08	-0.08
Net Tangible Assets	0.64	0.95	-0.66	0.39	-0.23	0.57	0.6	0.14	0.08	0.06	0.26	0.84	0.28		-0.12	0.72	0.1	-0.06	0.66	0.52	0.64	0.46
Capital Surpluse	0.49	0.01	0.0	-0.93	0.82	0.6	0.49	0.75	0.75	0.77	0.18	-0.48	0.4	-0.12		-0.39	0.91	-0.96	-0.8	-0.83	-0.44	-0.29
Deferred Long Term Liab	0.35	0.59	-0.13	0.52	-0.22	0.28	0.09	-0.08	-0.2	-0.13	-0.16	0.66	0.03	0.72	-0.39		-0.31	0.33	0.67	0.7	0.36	0.3
Short Long Term Debt	0.63	0.24	-0.24	-0.78	0.72	0.73	0.57	0.73	0.75	0.73	0.19	-0.26	0.31	0.1	0.91	-0.31		-0.98	-0.6	-0.64	-0.31	-0.18
Long Term Debt Total	-0.63	-0.2	0.19	0.83	-0.75	-0.73	-0.59	-0.74	-0.77	-0.75	-0.23	0.32	-0.37	-0.06	-0.96	0.33	-0.98		0.66	0.71	0.33	0.21
Net Invested Capital	-0.05	0.55	-0.42	0.95	-0.74	-0.15	-0.02	-0.5	-0.55	-0.58	0.04	0.85	-0.15	0.66	-0.8	0.67	-0.6	0.66		0.92	0.74	0.59
Net Working Capital	-0.05	0.4	-0.27	0.91	-0.59	-0.12	-0.22	-0.53	-0.54	-0.58	-0.01	0.73	-0.4	0.52	-0.83	0.7	-0.64	0.71	0.92		0.53	0.41
Capital Stock	0.03	0.58	-0.78	0.64	-0.59	-0.04	0.5	-0.26	-0.16	-0.38	0.12	0.65	0.08	0.64	-0.44	0.36	-0.31	0.33	0.74	0.53		0.72
Net Receivables	-0.06	0.46	-0.58	0.52	-0.3	-0.07	0.33	-0.17	-0.26	-0.33	0.1	0.52	-0.08	0.46	-0.29	0.3	-0.18	0.21	0.59	0.41	0.72

Click cells to compare fundamentals

About Minerva Neurosciences Financial Statements

Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	56.9 M	88 M
Intangibles To Total Assets	0.26	0.48

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Minerva Stock Analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC